282 related articles for article (PubMed ID: 31412737)
21. Engineering of a membrane-triggered activity switch in coagulation factor VIIa.
Nielsen AL; Sorensen AB; Holmberg HL; Gandhi PS; Karlsson J; Buchardt J; Lamberth K; Kjelgaard-Hansen M; Ley CD; Sørensen BB; Ruf W; Olsen OH; Østergaard H
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12454-12459. PubMed ID: 29109275
[TBL] [Abstract][Full Text] [Related]
22. Hemextin AB complex, a unique anticoagulant protein complex from Hemachatus haemachatus (African Ringhals cobra) venom that inhibits clot initiation and factor VIIa activity.
Banerjee Y; Mizuguchi J; Iwanaga S; Kini RM
J Biol Chem; 2005 Dec; 280(52):42601-11. PubMed ID: 16204244
[TBL] [Abstract][Full Text] [Related]
23. Substitution of aspartic acid for methionine-306 in factor VIIa abolishes the allosteric linkage between the active site and the binding interface with tissue factor.
Persson E; Nielsen LS; Olsen OH
Biochemistry; 2001 Mar; 40(11):3251-6. PubMed ID: 11258943
[TBL] [Abstract][Full Text] [Related]
24. Factor VIIa-induced interaction with integrin controls the release of tissue factor on extracellular vesicles from endothelial cells.
Rothmeier AS; Versteeg HH; Ruf W
J Thromb Haemost; 2019 Apr; 17(4):627-634. PubMed ID: 30740873
[TBL] [Abstract][Full Text] [Related]
25. A single-domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor.
Ferrière S; Kawecki C; Ottavi JF; Denis CV; Kauskot A; Christophe OD; Lenting PJ
J Thromb Haemost; 2019 Dec; 17(12):2035-2046. PubMed ID: 31423724
[TBL] [Abstract][Full Text] [Related]
26. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
Hoffman M; Monroe DM
Semin Hematol; 2001 Oct; 38(4 Suppl 12):6-9. PubMed ID: 11735103
[TBL] [Abstract][Full Text] [Related]
27. Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo.
Kopec AK; Spada AP; Contreras PC; Mackman N; Luyendyk JP
Toxicol Sci; 2018 Apr; 162(2):396-405. PubMed ID: 29228388
[TBL] [Abstract][Full Text] [Related]
28. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
[TBL] [Abstract][Full Text] [Related]
29. Tissue Factor Residues That Modulate Magnesium-Dependent Rate Enhancements of the Tissue Factor/Factor VIIa Complex.
Gajsiewicz JM; Nuzzio KM; Rienstra CM; Morrissey JH
Biochemistry; 2015 Aug; 54(30):4665-71. PubMed ID: 26169722
[TBL] [Abstract][Full Text] [Related]
30. Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells.
Demetz G; Seitz I; Stein A; Steppich B; Groha P; Brandl R; Schömig A; Ott I
Atherosclerosis; 2010 Oct; 212(2):466-71. PubMed ID: 20708733
[TBL] [Abstract][Full Text] [Related]
31. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets.
Monroe DM; Hoffman M; Roberts HR
Blood Coagul Fibrinolysis; 1996 Jun; 7(4):459-64. PubMed ID: 8839998
[TBL] [Abstract][Full Text] [Related]
32. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation.
Spiezia L; Campello E; Valle FD; Woodhams B; Simioni P
Clin Chem Lab Med; 2017 Mar; 55(4):484-488. PubMed ID: 27522621
[TBL] [Abstract][Full Text] [Related]
33. CD248 enhances tissue factor procoagulant function, promoting arterial and venous thrombosis in mouse models.
Kapopara PR; Safikhan NS; Huang JL; Meixner SC; Gonzalez K; Loghmani H; Ruf W; Mast AE; Lei V; Pryzdial ELG; Conway EM
J Thromb Haemost; 2021 Aug; 19(8):1932-1947. PubMed ID: 33830628
[TBL] [Abstract][Full Text] [Related]
34. Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes.
Lin BH; Sutherland MR; Rosell FI; Morrissey JH; Pryzdial ELG
J Thromb Haemost; 2020 Jun; 18(6):1370-1380. PubMed ID: 32145149
[TBL] [Abstract][Full Text] [Related]
35. Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex.
Sato Y; Asada Y; Marutsuka K; Hatakeyama K; Kamikubo Y; Sumiyoshi A
Thromb Haemost; 1997 Sep; 78(3):1138-41. PubMed ID: 9308767
[TBL] [Abstract][Full Text] [Related]
36. An unusual antibody that blocks tissue factor/factor VIIa function by inhibiting cleavage only of macromolecular substrates.
Fiore MM; Neuenschwander PF; Morrissey JH
Blood; 1992 Dec; 80(12):3127-34. PubMed ID: 1467519
[TBL] [Abstract][Full Text] [Related]
37. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa.
Fiore MM; Neuenschwander PF; Morrissey JH
J Biol Chem; 1994 Jan; 269(1):143-9. PubMed ID: 8276788
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of factor VIIa by antithrombin in vitro, ex vivo and in vivo: role of tissue factor and endothelial cell protein C receptor.
Vatsyayan R; Kothari H; Mackman N; Pendurthi UR; Rao LV
PLoS One; 2014; 9(8):e103505. PubMed ID: 25102166
[TBL] [Abstract][Full Text] [Related]
39. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface.
Kunzelmann-Marche C; Satta N; Toti F; Zhang Y; Nawroth PP; Morrissey JH; Freyssinet JM
Thromb Haemost; 2000 Feb; 83(2):282-9. PubMed ID: 10739387
[TBL] [Abstract][Full Text] [Related]
40. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation.
Furukawa S; Nogami K; Ogiwara K; Shima M
Int J Hematol; 2019 Apr; 109(4):390-401. PubMed ID: 30756344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
